Thirty senators have given the Department of Health and Human Services until Aug. 25 to explain how it selected roughly 150 health services research grants for cancellation, and to produce any written criteria, rankings, or analyses used to make those decisions.
The dispute is narrower and more concrete than the usual argument about federal spending priorities. It is about whether an executive agency may decline to spend money appropriated by Congress and whether the agency documented a basis for terminating specific awards. HHS has not publicly released selection criteria.
For patients, the grants at issue are unusually close to the bedside. The Agency for Healthcare Research and Quality funds work on how care is actually delivered: preventing falls in hospitals, reducing medication errors, and improving diagnosis. This is not basic science on a twenty-year horizon.
One Form Letter Went to Roughly 150 Grantees
The sequence described in the letter to HHS Secretary Robert F. Kennedy Jr. is specific. On July 15, approximately 150 AHRQ grantees received what the senators characterize as a generic form letter notifying them that their grants were canceled effective immediately. For many recipients, the senators wrote, it was the first communication they had received from the agency in nearly a year.
The senators' central procedural objection concerns what the letters did and did not say. The cancellation notices cite regulations requiring the agency to consider a grantee's progress, management practices, and the availability of funds. According to the letter, none of the notices substantively addressed any of those factors. Instead, the notices listed agency priorities that do not appear in the cited regulatory subsections. The senators note that many canceled grants were investigating topics AHRQ itself has described as priorities, and that identical language across a broad range of recipients suggests categorical denial rather than individual determinations.
The letter also describes a funding backlog separate from the cancellations. Since Oct. 1 of last year, the senators wrote, the agency has awarded only 5 percent of the funds available for extramural grants, leaving roughly $200 million that must be obligated before the fiscal year ends on Sept. 30. They attribute part of that to staffing, stating that AHRQ lost 80 percent of its staff last year, including most personnel who vet applications and manage awards.
The letter was signed by Senators Richard Blumenthal and Tammy Baldwin along with 28 Democratic and independent colleagues, and was announced by Senator Tammy Duckworth's office. Their demand is unambiguous: "We demand that you immediately rescind these cancellations."
These are the senators' characterizations. No court, inspector general or committee has made findings on whether the terminations were lawful or whether the process was defective, and HHS has not responded publicly.
The Legal Question Is Older Than This Administration
The governance issue has a name and a statute behind it. When Congress appropriates money, the executive branch is generally obligated to spend it. The Impoundment Control Act of 1974 was enacted after President Richard Nixon refused to spend appropriated funds, and it sets out the process an administration must follow if it wants to withhold or delay obligated money, including notifying Congress.
Congress appears to have anticipated friction of this kind in the current fiscal year. The Labor HHS appropriations agreement for the current fiscal year directs HHS to consult with the appropriations committees before terminating grants and to notify them in advance, requires advance notice before implementing restrictions that would delay disbursement to grantees, and directs the department to process disbursements within five business days absent extraordinary circumstances. It also includes legislative text requiring HHS to support staffing levels necessary to fulfill its statutory responsibilities. That bill was enacted in early February as part of a bipartisan package.
Report language of that kind carries less legal force than statutory text, and the practical remedy when an agency does not follow it is political and eventually judicial rather than automatic. That is part of why the senators are asking for documents rather than simply asserting a violation. The requested materials would establish whether individualized determinations were made.
Falls, Sepsis, and Antibiotic Overuse Were Among the Canceled Projects
The letter lists examples of terminated work, and the list is worth reading as a description of what health services research is. It includes training rural health care workers in Connecticut to respond to maternal medical emergencies, research in New York on improving access to home dialysis, a Colorado program reducing fall risk factors in rural hospitals, work in Utah to reduce antibiotic overuse at hospital discharge, research in Wisconsin testing artificial intelligence to improve the experience of hospitalized children and their families, a North Carolina grant that improved autism screening and services among Black children, research in Maryland on patient safety through telehealth, work in Virginia equipping primary care providers with chronic pain treatment approaches that reduce opioid reliance, and research in Michigan on patient financial burden after COVID-19 infection.
The senators say the cancellations disrupted nearly 200 research programs across nearly 30 states. They also wrote that programs across the country were forced to lay off staff, discontinue research, or shut down entirely.
The near-term consequence for patients is indirect and slow. Nothing about this changes the clinic appointment next week. What it changes is the pipeline that produces the protocols hospitals adopt three and five years out, in areas where the United States performs poorly by its own measures. The same appropriations package rejected the administration's proposal to substantially cut public health funding, which sets the backdrop for the current disagreement over execution.
Patients who want to act on this have ordinary options rather than special ones. Contacting a congressional office is the direct route, and university and hospital research offices can say whether local projects were affected. Nothing here warrants changing medical care or delaying treatment.
The senators requested a response by Aug. 25 and asked for documentation of grants management staffing levels as of three specific dates. The unobligated extramural funds must be awarded before Oct. 1 or they lapse. MedicalDaily will report the department's response and any subsequent congressional or legal action.
Key Questions Answered
What is AHRQ, and what does it fund? The Agency for Healthcare Research and Quality is the HHS agency that funds health services research, meaning studies of how care is delivered rather than basic biology. Its portfolio covers patient safety, diagnostic accuracy, care transitions and health care costs.
What exactly happened on July 15? Roughly 150 grantees received cancellation notices effective immediately, according to the senators' letter. The senators say the notices used identical language and did not address the factors the cited regulations require the agency to consider.
Can an agency simply decline to spend appropriated money? Generally no. The Impoundment Control Act of 1974 requires an administration that wants to withhold or delay appropriated funds to follow a defined process, including notifying Congress. Whether that applies here has not been adjudicated.
Has HHS explained how grants were selected? Not publicly. The senators are specifically requesting any written criteria, instructions, funding plans, rankings, spreadsheets or analyses used to identify affected grants.
What kind of research was canceled? Examples in the letter include rural maternal emergency training, home dialysis access, hospital fall prevention, reducing antibiotic overuse at discharge, autism screening for Black children, telehealth patient safety, and chronic pain treatment that reduces opioid reliance.
Does this affect my medical care right now? No. The effect is on future evidence that informs hospital protocols and clinical guidelines, not on care being delivered today.
What happens next? The senators requested a response by Aug. 25. Roughly $200 million in extramural research funding must be awarded before Oct. 1, or it lapses at the end of the fiscal year.
